Endocannabinoid System Activator (Neuritek Therapeutics)

N/A

Report date: 2025/01/26 19:18:24
NME

Base Information

Drug NameEndocannabinoid System Activator (Neuritek Therapeutics)
Drug Alias Namenext-generation PTSD therapeutics (Neuritek Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid receptor agonists
TargetsCannabinoid receptor
Therapy Area/IndicationsStress Disorders, Post-TraumaticMental Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeuritek Therapeutics Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsStress Disorders, Post-Traumatic
Inactive IndicationsMental Disorders

Other Information

ATC CodeN/A
Related LinksN/A